➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
McKesson
Boehringer Ingelheim
Colorcon
Express Scripts

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Apple Inc. v. Princeps Interface Technologies LLC (N.D. Cal. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Apple Inc. v. Princeps Interface Technologies LLC (N.D. Cal. 2019)

Docket   Start Trial Date Filed 2019-10-04
Court District Court, N.D. California Date Terminated
Cause 28:2201 Declaratory Judgement Assigned To Edward Milton Chen
Jury Demand Plaintiff Referred To
Parties APPLE INC.; PRINCEPS INTERFACE TECHNOLOGIES LLC
Patents 10,028,963; 10,391,075; 10,391,094; 7,208,288; 8,597,680; 8,680,103; 9,072,680; 9,102,573; 9,415,102; 9,415,103; 9,597,281; 9,597,288; 9,597,374; 9,703,102
Attorneys Jason Matthew Richardson
Firms Shook, Hardy & Bacon; Shook, Hardy & Bacon LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Apple Inc. v. Princeps Interface Technologies LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Apple Inc. v. Princeps Interface Technologies LLC

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Apple Inc. v. Princeps Interface Technologies LLC (N.D. Cal. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-05-11 60 Answer to Counterclaim 10. Apple admits that the face of the’963 patent states that provisional patent application….S. Patent No. 6,703,963 (“the ‘963 patent”). Apple further admits that the face 14 of the ‘963 patent…including at 27 least claim 1, of the ‘963 patent are invalid. 28 Apple’s Answer and Counterclaims… COUNT I - INFRINGEMENT OF U.S. PATENT NO. 6,703,963 10 19. Apple incorporates by…Apple admits that the face of the ‘963 patent bears a “Date of Patent” of March 9, 13 2004 and is titled External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
Mallinckrodt
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.